Company: KNRX
Filing Date: 2025-03-05
Form Type: F-1/A
Source: 0001493152-25-009104
Chunk: 275

Company: KNOREX LTD.
Filing Date: 2025-03-05
Form: F-1/A
Chunk 275
---
 sale of Class A ordinary shares by our Resale Shareholders.

Any shares sold by our Resale Shareholders until our Class A ordinary shares are listed or quoted on an established public trading market will take place at US$[●], which is the public offering price of the Class A ordinary shares we are selling in our initial public offering. Thereafter, any sales will occur at prevailing market prices or in privately negotiated prices. The distribution of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers’ transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals. Usual and customary or specifically negotiated brokerage fees or commissions may be paid by our Resale Shareholders. No sales of the shares covered by this prospectus shall occur until the Class A ordinary shares sold in our initial public offering begin trading on the NYSE American.

On ___________, 2025, a registration statement under the Securities Act with respect to our initial public offering of Class A ordinary shares was declared effective by the Securities and Exchange Commission. We estimate that we will receive net proceeds from this offering of approximately US$[●] million, or US$[●] million if the underwriters exercise their option to purchase additional Class A ordinary shares in full, after deducting underwriting discounts, commissions and the estimated offering expenses payable by us and based upon an assumed initial offering price of US$4.75 per Class A ordinary share (the mid-point of the estimated public offering price range shown on the front cover of this prospectus).

Concurrent with our initial public offering, our Class A ordinary shares were listed on the NYSE American under the symbol “KNRX.”

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, as amended, and a “foreign private issuer” under applicable U.S. federal securities laws and, as such, are eligible for reduced public company reporting requirements. See “Prospectus Summary – Implications of Being an Emerging Growth Company” and “Prospectus Summary – Implications of Being a Foreign Private Issuer” beginning on page 8 of the public offering prospectus for more information.

KNOREX LTD. was incorporated as an exempted company under the laws of the Cayman Islands without any operations of its own. We conduct our operations primarily in the United States, Singapore, Vietnam, India and Malaysia through our operating subsidiaries. The Class A ordinary shares offered in this offering are shares of the